DE69833949D1 - Mutierte klasse-i-mhc-moleküle - Google Patents

Mutierte klasse-i-mhc-moleküle

Info

Publication number
DE69833949D1
DE69833949D1 DE69833949T DE69833949T DE69833949D1 DE 69833949 D1 DE69833949 D1 DE 69833949D1 DE 69833949 T DE69833949 T DE 69833949T DE 69833949 T DE69833949 T DE 69833949T DE 69833949 D1 DE69833949 D1 DE 69833949D1
Authority
DE
Germany
Prior art keywords
mhc molecules
mutated class
class
mutated
beta2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69833949T
Other languages
English (en)
Other versions
DE69833949T2 (de
Inventor
David N Garboczi
Juergen B Walter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69833949D1 publication Critical patent/DE69833949D1/de
Application granted granted Critical
Publication of DE69833949T2 publication Critical patent/DE69833949T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Removal Of Specific Substances (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69833949T 1997-08-29 1998-08-20 Mutierte klasse-i-mhc-moleküle Expired - Lifetime DE69833949T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US920413 1997-08-29
US08/920,413 US6248564B1 (en) 1997-08-29 1997-08-29 Mutant MHC class I molecules
PCT/US1998/017308 WO1999011775A1 (en) 1997-08-29 1998-08-20 Mutant mhc class i molecules

Publications (2)

Publication Number Publication Date
DE69833949D1 true DE69833949D1 (de) 2006-05-11
DE69833949T2 DE69833949T2 (de) 2007-02-22

Family

ID=25443710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69833949T Expired - Lifetime DE69833949T2 (de) 1997-08-29 1998-08-20 Mutierte klasse-i-mhc-moleküle

Country Status (5)

Country Link
US (1) US6248564B1 (de)
EP (1) EP1017799B1 (de)
AT (1) ATE321131T1 (de)
DE (1) DE69833949T2 (de)
WO (1) WO1999011775A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264965B2 (en) 1998-06-05 2007-09-04 Alexis Biotech Limited Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
GB2339782A (en) * 1998-06-05 2000-02-09 Philip Michael Savage Chimeric protein complexes comprising HLA class I antigens
US7521197B2 (en) 1998-06-05 2009-04-21 Alexis Biotech Limited Method for producing cytotoxic T-cells
US20040209314A1 (en) 1999-09-06 2004-10-21 Institut National De La Sante Et De La Recherche Medicale France Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
FR2798128B1 (fr) * 1999-09-06 2001-11-16 Inst Nat Sante Rech Med Moyens de detection et de purification de populations lymphocytaires t cd8+ specifiques de peptides presentes dans le contexte hla
US20040191260A1 (en) 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
JP2004503213A (ja) * 2000-03-27 2004-02-05 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド 1本鎖クラスi主要組織適合性複合体、それをコードする構築物およびそれを生成する方法
US8022190B2 (en) * 2001-06-19 2011-09-20 Technion Research & Development Foundation Ltd. Immuno-molecules containing viral proteins, compositions thereof and methods of using
US20110045005A1 (en) 2001-10-19 2011-02-24 Craig Crowley Compositions and methods for the treatment of tumor of hematopoietic origin
US20090068178A1 (en) * 2002-05-08 2009-03-12 Genentech, Inc. Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
WO2004039324A2 (en) * 2002-10-28 2004-05-13 Genzyme Corporation Anti-hiv (sl9) compounds
CA2518237A1 (en) * 2003-03-04 2004-09-16 Greenville Hospital System Antitumor agents comprising a targeting portion and an immune response triggering portion
US20040210037A1 (en) * 2003-03-28 2004-10-21 Vaccinex, Inc. Targeted MHC class I alpha3 vaccine delivery systems
US20050042218A1 (en) * 2003-07-10 2005-02-24 Vaccinex, Inc. MHC class I - peptide-antibody conjugates with modified beta2-microglobulin
US9090673B2 (en) * 2003-12-12 2015-07-28 City Of Hope Synthetic conjugate of CpG DNA and T-help/CTL peptide
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
KR101270829B1 (ko) * 2004-09-23 2013-06-07 제넨테크, 인크. 시스테인 유전자조작 항체 및 접합체
US20090061478A1 (en) * 2006-01-30 2009-03-05 Lene Have Poulsen High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry
AU2007243946B2 (en) 2006-04-05 2012-11-29 Curis, Inc. Method for using BOC/CDO to modulate hedgehog signaling
ES2549128T3 (es) * 2006-05-19 2015-10-23 Technion Research And Development Foundation Ltd. Proteínas de fusión, usos de las mismas y procesos para producir las mismas
GB2442048B (en) * 2006-07-25 2009-09-30 Proimmune Ltd Biotinylated MHC complexes and their uses
US8617531B2 (en) * 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
JP5357782B2 (ja) * 2007-02-21 2013-12-04 バクシネックス インコーポレーティッド 抗原負荷CD1d分子によるNKT細胞活性の調節
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP3023436A1 (de) 2007-07-03 2016-05-25 Dako Denmark A/S Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
WO2009012256A1 (en) * 2007-07-16 2009-01-22 Genentech, Inc. Humanized anti-cd79b antibodies and immunoconjugates and methods of use
CL2008002085A1 (es) 2007-07-16 2008-11-21 Genentech Inc Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
EP2197908A2 (de) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika
MX2010003718A (es) * 2007-10-19 2010-04-21 Genentech Inc Anticuerpos anti-tenb2 producidos por ingenieria de cisteina y conjugados de farmaco y anticuerpo.
EP2244729B1 (de) 2008-01-18 2016-11-02 MedImmune, LLC Cystein-manipulierte antikörper zur stellenspezifischen konjugation
PL2247620T3 (pl) 2008-01-31 2017-08-31 Genentech, Inc. Przeciwciała anty-CD79B i immunokoniugaty i sposoby stosowania
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2010009735A2 (en) * 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) * 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
JP2012514476A (ja) 2009-01-08 2012-06-28 アルバート アインシュタイン カレッジ オブ メディシン オブ イェシバ ユニバーシティ,ア ディビジョン オブ イェシバ ユニバーシティ 細胞壁結合セラミド様糖脂質による細菌ワクチンおよびその使用
WO2010106535A1 (en) 2009-03-15 2010-09-23 Technion Research And Development Foundation Ltd. Soluble hla complexes for use in disease diagnosis
WO2010120561A1 (en) * 2009-04-01 2010-10-21 Genentech, Inc. Anti-fcrh5 antibodies and immunoconjugates and methods of use
CN102369218B (zh) 2009-04-01 2014-07-16 霍夫曼-拉罗奇有限公司 抗-FcRH5抗体和免疫缀合物以及应用方法
JP5918129B2 (ja) 2009-06-22 2016-05-18 メディミューン,エルエルシー 部位特異的共役のための操作されたFc領域
MX338694B (es) 2009-11-30 2016-04-27 Genentech Inc Composiciones y metodos para el diagnostico y el tratamiento de tumores.
PE20130214A1 (es) 2010-02-23 2013-03-11 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores
EP2566893A1 (de) 2010-05-03 2013-03-13 F. Hoffmann-La Roche AG Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
WO2011146568A1 (en) 2010-05-19 2011-11-24 Genentech, Inc. Predicting response to a her inhibitor
WO2011156328A1 (en) 2010-06-08 2011-12-15 Genentech, Inc. Cysteine engineered antibodies and conjugates
KR102057356B1 (ko) 2012-02-27 2019-12-18 아뮤닉스 파마슈티컬스, 인크. Xten 콘주게이트 조성물 및 그의 제조 방법
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
AR096687A1 (es) 2013-06-24 2016-01-27 Genentech Inc Anticuerpos anti-fcrh5
BR122021025087B1 (pt) 2013-12-17 2023-04-04 Genentech, Inc Anticorpo anti-cd3, célula hospedeira procariótica, método de produção do anticorpo biespecífico, imunoconjugado, composição, uso do anticorpo biespecífico e kit
CN107108724A (zh) 2014-09-12 2017-08-29 豪夫迈·罗氏有限公司 半胱氨酸改造抗体和缀合物
DK3262071T3 (da) 2014-09-23 2020-06-15 Hoffmann La Roche Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater
AU2016280102B2 (en) 2015-06-16 2022-06-16 Genentech, Inc. Humanized and affinity matured antibodies to FcRH5 and methods of use
MA44334A (fr) 2015-10-29 2018-09-05 Novartis Ag Conjugués d'anticorps comprenant un agoniste du récepteur de type toll
TW202332461A (zh) * 2016-08-11 2023-08-16 荷蘭商凱特製藥歐洲公司 製造和使用可溶性主要組織相容性複合體(mhc)分子類之方法
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation
EP3719033A1 (de) * 2019-04-02 2020-10-07 imusyn GmbH & Co. KG Stabilisiertes mhc i
WO2021007338A1 (en) 2019-07-08 2021-01-14 Imcare Biotech, Llc. Anti-serine protease inhibitor kazal (spik) antibodies, immunoconjugates, and methods of use
WO2021050217A1 (en) 2019-09-11 2021-03-18 Imcare Biotech, Llc. Epitopes of anti-serine protease inhibitor kazal (spik) antibodies
JP2023507120A (ja) 2019-12-18 2023-02-21 テネオフォー, インコーポレイテッド Cd38に結合する重鎖抗体
WO2022271987A1 (en) 2021-06-23 2022-12-29 TeneoFour, Inc. Anti-cd38 antibodies and epitopes of same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006916B1 (de) 1977-09-28 1981-07-08 National Research Development Corporation MHC-Antigene enthaltende immunologische Präparate und deren Herstellung
DE3063736D1 (en) 1979-03-27 1983-07-21 Nat Res Dev Improvements in or relating to immunological preparations
US4698420A (en) 1985-02-25 1987-10-06 Xoma Corporation Antibody hybrid molecules and process for their preparation
US5153265A (en) 1988-01-20 1992-10-06 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
DE3825615A1 (de) 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells

Also Published As

Publication number Publication date
ATE321131T1 (de) 2006-04-15
US6248564B1 (en) 2001-06-19
EP1017799A4 (de) 2004-08-04
WO1999011775A1 (en) 1999-03-11
EP1017799B1 (de) 2006-03-22
EP1017799A1 (de) 2000-07-12
DE69833949T2 (de) 2007-02-22

Similar Documents

Publication Publication Date Title
ATE321131T1 (de) Mutierte klasse-i-mhc-moleküle
DE60010098D1 (de) 28-epirapaloge
MY108864A (en) Peptide-carbohydrate conjugates generating t-cell immunity
DE59903442D1 (de) Azidfreie, gaserzeugende Zusammensetzung
CY1117235T1 (el) Νεϊσσεριακες συνθεσεις συνδυασμου
ATE296105T1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
DE69730202D1 (de) Azidfreie, gaserzeugende zusammensetzungen
CY1106789T1 (el) Γενικος φορεας για στοχευση μοριων σε κυτταρα που εκφραζουν gb3 υποδοχεα
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
PT996668E (pt) Composicoes aquosas termofixas
DE122004000025I2 (de) Borons{ure-und-esterverbindungen, deren Systhese und Verwendungen
HK1028417A1 (en) Cysteine rich receptors-train
BG105028A (en) Bridged indenopyrrolocarbazoles
NO20035597L (no) Forbedrede chelator-konjugater
ES2175734T3 (es) Composiciones de lavado y de acondicionamiento a base de silicona y de goma de galactomanano hidrofoba.
CY1108526T1 (el) Εμβολια εναντι καρκινων
DE59902827D1 (de) Azidfreie, gaserzeugende Zusammensetzung
DE19981910T1 (de) Gasbildende Zusammensetzung
NO20031860D0 (no) Kahalaolid F
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
BR0115065A (pt) Dispositivo de radiotelefonia formatável
DE50010265D1 (de) Azidfreie gaserzeugende Zusammensetzung
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
BG106316A (en) Ambroxol-containing lozenge
EA200000603A1 (ru) Конъюгаты, которые можно использовать при лечении рака предстательной железы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition